Skip to content

Saturday, June 28, 2025

Latest:

A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease
From a terrifying diagnosis to training for a marathon: Abigail’s miracle story
Researchers uncover rare gene variants contributing to systemic sclerosis risk

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

pediatric liver cancer

Novel combination therapy offers promising results for treatment-refractory hepatoblastoma

February 20, 2024 Chemotherapy, HDAC, hepatoblastoma, panobinostat, pediatric liver cancer, Research

Hepatoblastoma (HB) is the most common liver cancer in children. Researchers and physicians in the field are concerned because in the last decade HB has

Molecular profiling identifies new high-risk subtype of pediatric liver cancer

May 24, 2022 cancer treatment, diagnostic algorithm for cancer, hepatoblastoma, hepatocellular carcinoma, molecular profiling, pediatric liver cancer, Research

The findings support a diagnostic algorithm to identify the cancer subtype and guide specialized treatment.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951